Edition: International
Friday 05 December, 2025
BREAKING NEWS

Sresan Pharma Cough Syrup Case: ED Attaches Properties Worth Rs 2.04 Crore

  • News
    • Kochi
    • Trivandrum
    • Kozhikode
  • Sports
  • Business
  • Health
  • Entertainment
    • E24hrs
    • Cinema
    • Directors
    • Actors
  • Education
    • Career
  • Automobile
  • Personalities
    • Political Leaders
  • Religion
    • Christian
      • Catholic
      • Latin Catholic
      • Syro Malabar
    • Hindu
    • Islam
  • Environment
  • More
    • Food
    • Wellness
    • Lifestyle
    • Beauty & Fashion
    • Fitness
    • Mental Health
    • Yoga
    • Video
  • മലയാളം
BREAKING NEWS
100Days: Thirike, Neestream and Gopi Make their Way into the India Book of Records
Samsung to Announce its DX Vision at ‘The First Look’ Event at CES 2026
Makers of Johnson’s Baby Supports Training of Over 2 Lakh Healthcare Workers
Air India Partners with Maldivian
Biennale Artist Mahama Tops Power 100; KBF’s Bose and Nadar Also Feature on List
KMB Invitations Programme from 13th Dec; 11 Projects in Seven Venues
    • News
      • Kochi
      • Trivandrum
      • Kozhikode
    • Sports
    • Business
    • Health
    • Entertainment
      • E24hrs
      • Cinema
      • Directors
      • Actors
    • Education
      • Career
    • Automobile
    • Personalities
      • Political Leaders
    • Religion
      • Christian
        • Catholic
        • Latin Catholic
        • Syro Malabar
      • Hindu
      • Islam
    • Environment
    • More
      • Food
      • Wellness
      • Lifestyle
      • Beauty & Fashion
      • Fitness
      • Mental Health
      • Yoga
      • Video
    • മലയാളം

    Tag: clinical evidence
  • Health
    • BDR Receives DCGI Approval for Favipiravir to Treat COVID-19

    MUMBAI: BDR Pharmaceuticals –today announced the launch of Favipiravir for the treatment of COVID-19 patients.

    NE ReporterAugust 5, 2020
  • Health
    • Roche Launches new Therapy Emicizumab for People with Hemophilia A

    MUMBAI: Roche announced that Emicizumab (Hemlibra®) has been approved in India for Hemophilia A with.

    NE ReporterApril 17, 2019
  • Business
    • Government of India Reaffirms the Safety of Johnson & Johnson’s Talc

    NEW DELHI: Johnson & Johnson has resumed production of its Johnson’s Baby Powder at plants.

    NE ReporterMarch 2, 2019

    Live Updates

    • Samsung to Announce its DX Vision at ‘The First Look’ Event at CES 2026
    • Makers of Johnson’s Baby Supports Training of Over 2 Lakh Healthcare Workers
    • Air India Partners with Maldivian
    • Biennale Artist Mahama Tops Power 100; KBF’s Bose and Nadar Also Feature on List
    • KMB Invitations Programme from 13th Dec; 11 Projects in Seven Venues

    NewsExperts.in

    • മലയാളം
    • മലയാളം

    What’s New ?

    • Samsung to Announce its DX Vision at ‘The First Look’ Event at CES 2026
    • Makers of Johnson’s Baby Supports Training of Over 2 Lakh Healthcare Workers
    • Air India Partners with Maldivian
    • Biennale Artist Mahama Tops Power 100; KBF’s Bose and Nadar Also Feature on List
    • KMB Invitations Programme from 13th Dec; 11 Projects in Seven Venues

    Newsexperts.in - powered by Klickevents Infosolutions (P) LTD